Since HDL is a well-defined reverse cholesterol transporter and ApoA1 is a major component of HDL that mediates cholesterol transportation22, our study highlights the potential of targeting the ApoA1/ABCA1/G1 pathway to restore cholesterol homeostasis in the TME and enhance macrophage function for improved tumor control. Here, APOA1 is linked to neoplasm.